259 related articles for article (PubMed ID: 27870968)
1. The cardiac maladaptive ATF3-dependent cross-talk between cardiomyocytes and macrophages is mediated by the IFNγ-CXCL10-CXCR3 axis.
Koren L; Barash U; Zohar Y; Karin N; Aronheim A
Int J Cardiol; 2017 Feb; 228():394-400. PubMed ID: 27870968
[TBL] [Abstract][Full Text] [Related]
2. ATF3-dependent cross-talk between cardiomyocytes and macrophages promotes cardiac maladaptive remodeling.
Koren L; Alishekevitz D; Elhanani O; Nevelsky A; Hai T; Kehat I; Shaked Y; Aronheim A
Int J Cardiol; 2015 Nov; 198():232-40. PubMed ID: 26201690
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis.
Basset L; Chevalier S; Danger Y; Arshad MI; Piquet-Pellorce C; Gascan H; Samson M
J Mol Med (Berl); 2015 Dec; 93(12):1355-67. PubMed ID: 26199110
[TBL] [Abstract][Full Text] [Related]
4. ATF3 expression in cardiomyocytes preserves homeostasis in the heart and controls peripheral glucose tolerance.
Kalfon R; Koren L; Aviram S; Schwartz O; Hai T; Aronheim A
Cardiovasc Res; 2017 Feb; 113(2):134-146. PubMed ID: 28082453
[TBL] [Abstract][Full Text] [Related]
5. JDP2 and ATF3 deficiencies dampen maladaptive cardiac remodeling and preserve cardiac function.
Kalfon R; Friedman T; Eliachar S; Shofti R; Haas T; Koren L; Moskovitz JD; Hai T; Aronheim A
PLoS One; 2019; 14(2):e0213081. PubMed ID: 30818334
[TBL] [Abstract][Full Text] [Related]
6. LAMP1 controls CXCL10-CXCR3 axis mediated inflammatory regulation of macrophage polarization during inflammatory stimulation.
Ye Y; Li L; Kang H; Wan Z; Zhang M; Gang B; Liu J; Liu G; Gu W
Int Immunopharmacol; 2024 May; 132():111929. PubMed ID: 38555817
[TBL] [Abstract][Full Text] [Related]
7. Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4
Hart M; Nickl L; Walch-Rueckheim B; Krammes L; Rheinheimer S; Diener C; Taenzer T; Kehl T; Sester M; Lenhof HP; Keller A; Meese E
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33229509
[TBL] [Abstract][Full Text] [Related]
8. Response letter: "ATF3: A promoter or inhibitor of cardiac maladaptive remodeling".
Koren L; Shaked Y; Aronheim A
Int J Cardiol; 2015 Dec; 201():692. PubMed ID: 26374759
[No Abstract] [Full Text] [Related]
9. Adult cardiac expression of the activating transcription factor 3, ATF3, promotes ventricular hypertrophy.
Koren L; Elhanani O; Kehat I; Hai T; Aronheim A
PLoS One; 2013; 8(7):e68396. PubMed ID: 23874609
[TBL] [Abstract][Full Text] [Related]
10. ATF3: A potential target for cardiac maladaptive remodeling.
Ma ZG; Wei WY; Xu SC; Zhang WB; Dai J; Tang QZ
Int J Cardiol; 2016 Jan; 202():50-1. PubMed ID: 26386920
[No Abstract] [Full Text] [Related]
11. Pleiotropic and puzzling effects of ATF3 in maladaptive cardiac remodeling.
Zhou H; Yuan Y; Ni J; Guo H; Deng W; Bian ZY; Tang QZ
Int J Cardiol; 2016 Mar; 206():87-8. PubMed ID: 26780683
[No Abstract] [Full Text] [Related]
12. Pathogenic roles of CXCL10 signaling through CXCR3 and TLR4 in macrophages and T cells: relevance for arthritis.
Lee JH; Kim B; Jin WJ; Kim HH; Ha H; Lee ZH
Arthritis Res Ther; 2017 Jul; 19(1):163. PubMed ID: 28724396
[TBL] [Abstract][Full Text] [Related]
13. CXCR3-independent actions of the CXC chemokine CXCL10 in the infarcted myocardium and in isolated cardiac fibroblasts are mediated through proteoglycans.
Saxena A; Bujak M; Frunza O; Dobaczewski M; Gonzalez-Quesada C; Lu B; Gerard C; Frangogiannis NG
Cardiovasc Res; 2014 Jul; 103(2):217-27. PubMed ID: 24891401
[TBL] [Abstract][Full Text] [Related]
14. ATF3: A promotion effect or a inhibition effect in cardiac maladaptive remodeling.
Yang J; Yang CJ; Yang J; Fan ZX
Int J Cardiol; 2015 Dec; 201():245-6. PubMed ID: 26301647
[No Abstract] [Full Text] [Related]
15. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.
Yuan J; Liu Z; Lim T; Zhang H; He J; Walker E; Shier C; Wang Y; Su Y; Sall A; McManus B; Yang D
Circ Res; 2009 Mar; 104(5):628-38. PubMed ID: 19168435
[TBL] [Abstract][Full Text] [Related]
16. Activating transcription factor 3 deficiency promotes cardiac hypertrophy, dysfunction, and fibrosis induced by pressure overload.
Zhou H; Shen DF; Bian ZY; Zong J; Deng W; Zhang Y; Guo YY; Li H; Tang QZ
PLoS One; 2011; 6(10):e26744. PubMed ID: 22053207
[TBL] [Abstract][Full Text] [Related]
17. Activating transcription factor 3 protects against pressure-overload heart failure via the autophagy molecule Beclin-1 pathway.
Lin H; Li HF; Chen HH; Lai PF; Juan SH; Chen JJ; Cheng CF
Mol Pharmacol; 2014 May; 85(5):682-91. PubMed ID: 24550138
[TBL] [Abstract][Full Text] [Related]
18. Cardiac Fibroblast-Specific Activating Transcription Factor 3 Protects Against Heart Failure by Suppressing MAP2K3-p38 Signaling.
Li Y; Li Z; Zhang C; Li P; Wu Y; Wang C; Bond Lau W; Ma XL; Du J
Circulation; 2017 May; 135(21):2041-2057. PubMed ID: 28249877
[TBL] [Abstract][Full Text] [Related]
19. Pressure overload inhibits glucocorticoid receptor transcriptional activity in cardiomyocytes and promotes pathological cardiac hypertrophy.
Matsuhashi T; Endo J; Katsumata Y; Yamamoto T; Shimizu N; Yoshikawa N; Kataoka M; Isobe S; Moriyama H; Goto S; Fukuda K; Tanaka H; Sano M
J Mol Cell Cardiol; 2019 May; 130():122-130. PubMed ID: 30946837
[TBL] [Abstract][Full Text] [Related]
20. Critical Role of the CXCL10/C-X-C Chemokine Receptor 3 Axis in Promoting Leukocyte Recruitment and Neuronal Injury during Traumatic Optic Neuropathy Induced by Optic Nerve Crush.
Ha Y; Liu H; Zhu S; Yi P; Liu W; Nathanson J; Kayed R; Loucas B; Sun J; Frishman LJ; Motamedi M; Zhang W
Am J Pathol; 2017 Feb; 187(2):352-365. PubMed ID: 27960090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
